Is this you? Create Your Porfile
Avatar

Gilmore Jeremy

Eli Lilly and Company

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Gilmore Jeremy is active.

Explore More

Publication

Featured researches published by Gilmore Jeremy.

Archive | 2004

Pharmaceutical compounds with serotonin receptor activity

Gilmore Jeremy; Lamas-Peteira Carlos; Torrado Alicia

Archive | 1998

TREATING AGENT FOR DISEASE OF CENTRAL NERVOUS SYSTEM

Ambler Samantha Jayne; Dell Colin Peter; Gilmore Jeremy; Hotten Terrence Michael; Sanchiz-Suarez Ana; Simmonds Robin George; Timms Graham Henry; Tupper David Edward; Urquhart Michel William John

Archive | 2008

3-AMINO-PYRROLIDINE ALS INHIBITOREN DER MONOAMIN- WIEDERAUFNAHME

Beadle Christopher D; Cases-Thomas Manuel J; Clark Barry Peter; Gallagher Peter T; Masters John Joseph; Timms Graham Henry; Walter Magnus W; Whatton Maria Ann; Wood Virginia Ann; Gilmore Jeremy

Archive | 2007

Isochromanforbindelser til behandling af CNS-lidelser

Agejas-Chicharro Francisco Javier; Bueno Melendo Ana Belen; Camp Nicholas Paul; Gilmore Jeremy; Lamas-Peteira Carlos; Timms Graham Henry; Williams Andrew Caerwyn

Archive | 2005

3-AMINOPIRROLIDINAS COMO INHIBIDORES DE LA CAPTACION DE MONOAMINAS

Cases-Thomas Manuel Javier; Wood Virginia Ann; Beadle Christopher David; Masters John Joseph; Timms Graham Henry; Walter Magnus Wilhelm; Whatton Maria Ann; Gallagher Peter Thadeus; Gilmore Jeremy; Clark Barry Peter

Archive | 2005

3-AMINOPIRROLIDINAS COMO INHIBIDORES DE LA CAPTACION DE MONOAMINA REF. X-15735

Beadle Christopher David; Cases-Thomas Manuel Javier; Clark Barry Peter; Gallagher Peter Thaddeus; Masters John Joseph; Timms Graham Henry; Walter Magnus Wilhelm; Whatton Maria Ann; Wood Virginia Ann; Gilmore Jeremy

Archive | 2005

PHARMAZEUTISCHE VERBINDUNGEN MIT SEROTONIN REZEPTOR AKTIVITÄT

Gilmore Jeremy; Lamas-Peteira Carlos; Torrado Alicia

Archive | 2004

Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um mamìfero, incluindo um humano, sofrendo de ou suscetìvel a um distúrbio do sistema nervoso central

Agejas-Chicharro Francisco Javier; Bueno-Melendo Ana Belen; Camp Nicholas Paul; Gilmore Jeremy; Lamas-Peteira Carlos; Timms Graham Henry; Williams Andrew Caerwyn

Archive | 2004

4-AMINO PIPERIDINAS N,N-DISUSTITUIDAS COMO INHIBIDORES DE LA CAPTACION DE MONOAMINA

Cases-Thomas Manuel Javier; Clark Barry Peter; Gallagher Peter Thaddeus; Wood Virginia Ann; Masters John Joseph; Timms Graham Henry; Whatton Maria Ann; Gilmore Jeremy

Archive | 2004

INHIBIDORES DE LA CAPTACION DE MONOAMINA

Clark Barry Peter; Thomas Manuel Javier Cases; Gallagher Peter Thaddeus; Gilmore Jeremy; Masters John Joseph; Timms Graham Henry; Whatton Maria Ann; Wood Virginia Ann

Explore More

Collaboration

Dive into the Gilmore Jeremy's collaboration.

Top Co-Authors
Avatar

Todd Alec

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Timms Graham Henry

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Clark Barry Peter

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Lamas-Peteira Carlos

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Masters John Joseph

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Whatton Maria Ann

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Wood Virginia Ann

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Gallagher Peter Thaddeus

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Torrado Alicia

Eli Lilly and Company

View shared research outputs
Top Co-Authors
Avatar

Beadle Christopher D

Eli Lilly and Company

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge